Buvacaina

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

39 API Suppliers, 7 USDMF, 7 CEP/COS, 1 JDMF, 6 EU WC, 2 KDMF, 19 NDC API, 20 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

10 Drugs in Development

10 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

140 FDF Dossiers, 82 FDA Orange Book, 9 Europe, 18 Canada, 6 South Africa, 25 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 0.25%, INJECTABLE;INJECTION - 0.25%;0.0091MG/ML, INJECTABLE;INJECTION - 0.5%, INJECTABLE;INJECTION - 0.5%;0.0091MG/ML, INJECTABLE;INJECTION - 0.75%, INJECTABLE;INJECTION - 0.75%;0.0091MG/ML, INJECTABLE;INJECTION - 0.25%, INJECTABLE;INJECTION - 0.5%, INJECTABLE;INJECTION - 0.5%;0.0091MG/ML, INJECTABLE;INJECTION - 0.75%, INJECTABLE;INJECTION - 0.75%;0.0091MG/ML, INJECTABLE;INJECTION - 0.5%;0.0091MG/ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 6 Actylis, 2 Kerry, 1 Microlex e.U, 2 Pluviaendo, 1 Roquette

EXCIPIENTS BY APPLICATIONS

9 Parenteral, 3 Fillers, Diluents & Binders, 2 Topical, 1 Co-Processed Excipients, 1 Taste Masking, 1 Film Formers & Plasticizers, 1 Coating Systems & Additives, 1 Controlled & Modified Release